Concepedia

Changyong Qiu

CQ

1

Publications

14

Citations

1

H-Index

2022

Active since

Affiliations

Betta Pharmaceuticals (China)(Current)

Changyong Qiu is an author at Betta Pharmaceuticals (China) specializing in tumor biology, molecular diagnostics, and cancer therapeutics.

Top concepts

Publications per year

2022–2022

1

Publications

1

Abstract 5462: BPI-361175, a 4th generation EGFR-TKI for the treatment of non-small cell lung cancer (NSCLC)

Lijia Liu, Changyong Qiu, Xiangyong Liu et al. · Cancer Research · 2022 · 14 citations

, , +20

Rows per page

1–1 of 1